Altered inhibitory interaction among inferior frontal and motor cortex in l-dopa-induced dyskinesias

Mov Disord. 2016 May;31(5):755-9. doi: 10.1002/mds.26520. Epub 2016 Feb 10.

Abstract

Background: Levodopa-induced dyskinesias are associated with thalamo-cortical disinhibition and frontal area overactivation. Neuroimaging and transcranial magnetic stimulation studies have highlighted the involvement of the right inferior frontal cortex in levodopa-induced dyskinesias.

Methods: Using transcranial magnetic stimulation, we tested connectivity between the inferior frontal and contralateral motor cortex in Parkinson's disease patients with and without levodopa-induced dyskinesias compared with age-matched controls. Furthermore, in dyskinetic patients, connectivity between the inferior frontal and contralateral motor cortex was assessed before and after a single session of continuous theta-burst stimulation applied over the inferior frontal cortex.

Results: Dyskinetic patients showed abnormal facilitatory connectivity between the inferior frontal and motor cortex when compared with the nondyskinetic group. Continuous theta-burst stimulation over the inferior frontal cortex eliminated such facilitatory connectivity and decreased the levodopa-induced dyskinesias that was induced by a supramaximal dose of levodopa.

Conclusion: In dyskinetic patients, a weaker inhibitory cortico-cortical interaction between the inferior frontal and contralateral motor cortex could be involved in levodopa-induced dyskinesias and restored by continuous theta-burst stimulation over the inferior frontal cortex. © 2016 Movement Disorder Society.

Keywords: Parkinson's disease; connectivity; inferior frontal cortex; levodopa-induced dyskinesia; transcranial magnetic stimulation.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antiparkinson Agents / adverse effects*
  • Dyskinesia, Drug-Induced / physiopathology*
  • Female
  • Frontal Lobe / physiopathology*
  • Humans
  • Levodopa / adverse effects*
  • Male
  • Middle Aged
  • Motor Cortex / physiopathology*
  • Parkinson Disease / drug therapy
  • Parkinson Disease / physiopathology*
  • Transcranial Magnetic Stimulation

Substances

  • Antiparkinson Agents
  • Levodopa